stockrow
Friday 6 November 2026
Export SNN’s income statement to Excel — free account
Smith & Nephew SNATS, Inc.
SNN Healthcare Medical Devices
Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.
31.12
0.89
−2.78%
Follow SNN
Alert me
Smith & Nephew SNATS, Inc. (SNN) Net margin
Smith & Nephew SNATS, Inc.'s net margin over the twelve months to 30 June 2023 was 6.71%. Over the past ten years it has ranged from 4.28% (fiscal 2022) to 16.8% (fiscal 2016); the current reading is higher than 64% of that period. That is above the Medical Devices industry median of −14.5% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 10.1% | 3.05 |
| FY2024 | 7.09% | 2.35 |
| FY2023 | 4.74% | 0.46 |
| FY2022 | 4.28% | (5.77) |
| FY2021 | 10.1% | 0.23 |
| FY2020 | 9.82% | (1.86) |
| FY2019 | 11.7% | (1.84) |
| FY2018 | 13.5% | (2.58) |
| FY2017 | 16.1% | (0.69) |
| FY2016 | 16.8% | 7.94 |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Jun 2023 | 6.27% | 4.52 |
| Dec 2022 | 1.75% | (5.08) |
| Jun 2022 | 6.83% | (5.37) |
| Dec 2021 | 12.2% | 4.29 |
| 6 more quarters | Free account |
Against its own ten years
Low 4.28%
High 16.8%
Ten-year median
10.1%
Current reading's percentile
64
Net margin against peers
| Company | Net margin |
|---|---|
| BIO.B Bio-Rad Laboratories, Inc. compare | 39.5% |
| BIO Bio-Rad Laboratories, Inc. compare | 39.5% |
| GMED Globus Medical, Inc. compare | 17.8% |
| PODD Insulet Corporation compare | 13.5% |
| PEN Penumbra, Inc. compare | 10.1% |
| SNN Smith & Nephew SNATS, Inc. | 6.71% |
| BRKR Bruker Corporation compare | −4.76% |
| TXG 10x Genomics compare | −12.2% |
| GKOS Glaukos Corporation compare | −24.6% |
| Medical Devices industry median | −14.5% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on SNN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement